Electrophilic borylation using BCl3 and benzothiadiazole to direct the C–H functionalisation of an adjacent aromatic unit produces fused boracyclic materials with minimally changed HOMO energies but significantly reduced LUMO energies.
A range of frustrated Lewis pairs (FLPs) containing borenium cations have been synthesised. The catechol (Cat)-ligated borenium cation [CatB(PtBu(3))](+) has a lower hydride-ion affinity (HIA) than B(C(6)F(5))(3). This resulted in H(2) activation being energetically unfavourable in a FLP with the strong base PtBu(3). However, ligand disproportionation of CatBH(PtBu(3)) at 100 °C enabled trapping of H(2) activation products. DFT calculations at the M06-2X/6-311G(d,p)/PCM (CH(2)Cl(2)) level revealed that replacing catechol with chlorides significantly increases the chloride-ion affinity (CIA) and HIA. Dichloro-borenium cations, [Cl(2)B(amine)](+), were calculated to have considerably greater HIA than B(C(6)F(5))(3). Control reactions confirmed that the HIA calculations can be used to successfully predict hydride-transfer reactivity between borenium cations and neutral boranes. The borenium cations [Y(Cl)B(2,6-lutidine)](+) (Y = Cl or Ph) form FLPs with P(mesityl)(3) that undergo slow deprotonation of an ortho-methyl of lutidine at 20 °C to form the four-membered boracycles [(CH(2){NC(5)H(3)Me})B(Cl)Y] and [HPMes(3)](+). When equimolar [Y(Cl)B(2,6-lutidine)](+)/P(mesityl)(3) was heated under H(2) (4 atm), heterolytic cleavage of dihydrogen was competitive with boracycle formation.
N-methylacridinium salts are Lewis acids with high hydride ion affinity but low oxophilicity. The cation forms a Lewis adduct with 4-(N,N-dimethylamino)pyridine but a frustrated Lewis pair (FLP) with the weaker base 2,6-lutidine which activates H2, even in the presence of H2O. Anion effects dominate reactivity, with both solubility and rate of H2 cleavage showing marked anion dependency. With the optimal anion, a N-methylacridinium salt catalyzes the reductive transfer hydrogenation and hydrosilylation of aldimines through amine-boranes and silanes, respectively. Furthermore, the same salt is active for the catalytic dehydrosilylation of alcohols (primary, secondary, tertiary, and ArOH) by silanes with no observable over-reduction to the alkanes.
Hail boration! 2‐Dimethylaminopyridine‐ligated dihaloborocations [X2B(2‐DMAP)]+ with a strained four‐membered boracycle were used for the haloboration of terminal and dialkyl internal alkynes (see scheme). Esterification then provided vinyl boronate esters as useful precursors to tetrasubstituted alkenes. Following mechanistic studies, the scope of the haloboration was expanded simply by variation of the amine. Pin=2,3‐dimethyl‐2,3‐butanedioxy.
Through this extensive structure–property study we show that critical micelle concentration correlates with self‐associative hydrogen bond complex formation constant, when combined with outputs from low level, widely accessible, computational models. Herein, we bring together a series of 39 structurally related molecules related by stepwise variation of a hydrogen bond donor–acceptor amphiphilic salt. The self‐associative and corresponding global properties for this family of compounds have been studied in the gas, solid and solution states. Within the solution state, we have shown the type of self‐associated structure present to be solvent dependent. In DMSO, this class of compound show a preference for hydrogen bonded dimer formation, however moving into aqueous solutions the same compounds are found to form larger self‐associated aggregates. This observation has allowed us the unique opportunity to investigate and begin to predict self‐association events at both the molecular and extended aggregate level.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.